Market Cap 57.01M
Revenue (ttm) 0.00
Net Income (ttm) -7.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.09
Volume 152,800
Avg Vol 1,883,728
Day's Range N/A - N/A
Shares Out 36.54M
Stochastic %K 55%
Beta 1.70
Analysts Strong Sell
Price Target $18.00

Latest News on BDRX

Notice of General Meeting

Apr 17, 2025, 8:30 AM EDT - 8 days ago

Notice of General Meeting


Preliminary Results for the Year Ended 31 December 2024

Apr 11, 2025, 8:30 AM EDT - 14 days ago

Preliminary Results for the Year Ended 31 December 2024


Result of General Meeting

Nov 22, 2024, 8:30 AM EST - 5 months ago

Result of General Meeting


Biodexa Announces Successful Appeal of Nasdaq Delisting

Oct 15, 2024, 4:15 PM EDT - 6 months ago

Biodexa Announces Successful Appeal of Nasdaq Delisting


Interim results for the six months ended June 30, 2024

Sep 26, 2024, 8:30 AM EDT - 7 months ago

Interim results for the six months ended June 30, 2024


ADR Ratio Change

Sep 19, 2024, 4:30 PM EDT - 7 months ago

ADR Ratio Change


Receipt of Nasdaq Delisting Determination - Plans to Appeal

Aug 30, 2024, 4:30 PM EDT - 8 months ago

Receipt of Nasdaq Delisting Determination - Plans to Appeal